A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

Clinical trial NCT00044681 · COMPLETED

Trial details

NCT number: NCT00044681
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder Depressive Disorder, Major Depression

Start date: 2002-10-01
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.